NO341475B1 - Anvendelse av serumfritt kulturmedium for å redusere oksiderte former av rekombinant dimerisk gonadotropin - Google Patents

Anvendelse av serumfritt kulturmedium for å redusere oksiderte former av rekombinant dimerisk gonadotropin Download PDF

Info

Publication number
NO341475B1
NO341475B1 NO20080580A NO20080580A NO341475B1 NO 341475 B1 NO341475 B1 NO 341475B1 NO 20080580 A NO20080580 A NO 20080580A NO 20080580 A NO20080580 A NO 20080580A NO 341475 B1 NO341475 B1 NO 341475B1
Authority
NO
Norway
Prior art keywords
concentration
cho
culture medium
serum
cells
Prior art date
Application number
NO20080580A
Other languages
English (en)
Norwegian (no)
Swedish (sv)
Other versions
NO20080580L (no
Inventor
Jean-Pierre Fonta
Paul Ducommun
Véronique Deparis
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of NO20080580L publication Critical patent/NO20080580L/no
Publication of NO341475B1 publication Critical patent/NO341475B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/59Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/0037Serum-free medium, which may still contain naturally-sourced components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/32Amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/38Vitamins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/44Thiols, e.g. mercaptoethanol
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2511/00Cells for large scale production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO20080580A 2005-07-05 2008-01-31 Anvendelse av serumfritt kulturmedium for å redusere oksiderte former av rekombinant dimerisk gonadotropin NO341475B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05106060 2005-07-05
US69707705P 2005-07-06 2005-07-06
PCT/EP2006/063862 WO2007003640A1 (en) 2005-07-05 2006-07-04 Serum-free culture medium for the production of recombinant gonadotropins

Publications (2)

Publication Number Publication Date
NO20080580L NO20080580L (no) 2008-01-31
NO341475B1 true NO341475B1 (no) 2017-11-27

Family

ID=35134140

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080580A NO341475B1 (no) 2005-07-05 2008-01-31 Anvendelse av serumfritt kulturmedium for å redusere oksiderte former av rekombinant dimerisk gonadotropin

Country Status (24)

Country Link
US (1) US8093052B2 (de)
EP (1) EP1899454B1 (de)
JP (1) JP5059757B2 (de)
KR (1) KR101346499B1 (de)
CN (1) CN101258236A (de)
AR (1) AR054157A1 (de)
AU (1) AU2006264917B2 (de)
BR (1) BRPI0612781B8 (de)
CA (1) CA2613867A1 (de)
CY (1) CY1112992T1 (de)
DK (1) DK1899454T3 (de)
EA (1) EA012840B1 (de)
ES (1) ES2388875T3 (de)
HR (1) HRP20120486T1 (de)
IL (1) IL188558A (de)
MY (1) MY149621A (de)
NO (1) NO341475B1 (de)
PL (1) PL1899454T3 (de)
PT (1) PT1899454E (de)
RS (1) RS52468B (de)
SI (1) SI1899454T1 (de)
TW (1) TWI369401B (de)
UA (1) UA91063C2 (de)
WO (1) WO2007003640A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101264096B (zh) * 2007-03-12 2011-11-09 中国医学科学院药物研究所 人参皂苷Rg1在制备生精产品中的应用
JP5570980B2 (ja) * 2007-06-28 2014-08-13 ラティオファーム ゲーエムベーハー Fsh生産細胞クローン
KR101848945B1 (ko) 2010-04-26 2018-04-16 노파르티스 아게 개선된 세포 배양 배지
CN102296047B (zh) * 2011-08-13 2013-03-13 新疆农垦科学院 利用羔羊超排卵母细胞生产体外胚胎的方法
KR102418824B1 (ko) * 2013-10-14 2022-07-11 아레스 트레이딩 에스.아. 포유동물의 고성능 유가식 배양을 위한 신규 배지
AU2016363789B2 (en) * 2015-12-02 2022-06-02 CSL Behring Lengnau AG Improved media for the expression of recombinant vitamin K-dependent proteins
CN105462909B (zh) * 2015-12-31 2019-09-27 哈药集团技术中心 一种高效表达人促卵泡激素的cho细胞的培养方法
CN108795841A (zh) * 2017-05-03 2018-11-13 上海奥浦迈生物科技有限公司 一种st培养基及其应用
CN110042137B (zh) * 2019-05-14 2023-02-28 上海赛迈生物科技有限公司 高密度灌注培养重组cho细胞生产人促卵泡激素的方法、培养基及其应用
US20220204920A1 (en) 2019-05-16 2022-06-30 Formycon Ag Method for reducing methionine oxidation in recombinant proteins
CN114836367A (zh) * 2022-04-28 2022-08-02 上海东富龙生物试剂有限公司 用于hek293细胞培养及腺病毒、腺相关病毒复制扩增的化学成分限定培养基

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4560655A (en) * 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
WO1995012664A1 (en) * 1993-11-03 1995-05-11 Genetics Institute, Inc. Adaption of mammalian cell lines to high cell densities

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3110559C2 (de) * 1981-03-18 1985-05-09 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Vollsynthetisches Zellkulturmedium
US4657866A (en) * 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
FR2600076A1 (fr) * 1986-06-12 1987-12-18 Fond Ctre Nal Transfusion Milieu de culture comportant de l'albumine humaine, procede de preparation d'un produit injectable a partir de ce milieu, produit obtenu et son utilisation, composition obtenue
US5122469A (en) * 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
GB9022545D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Culture medium
WO1998004680A1 (en) 1996-07-26 1998-02-05 University Of Manitoba Serum-free medium for growth of anchorage-dependant mammalian cells
JP2000517188A (ja) * 1996-08-30 2000-12-26 ライフ テクノロジーズ,インコーポレイテッド 無血清哺乳動物細胞培養培地およびその使用
DE69738806D1 (de) * 1996-10-10 2008-08-14 Invitrogen Corp Tierzellkulturmedium mit pflanzlichen nährstoffen
IL122732A0 (en) * 1997-01-15 1998-08-16 Akzo Nobel Nv Liquid gonadotropin-containing formulation its preparation and a device containing same
WO1999050390A1 (en) 1998-03-30 1999-10-07 Bionative Ab Methionin containing animal cell culture medium and its use
EP1452597A4 (de) * 2001-12-04 2006-09-20 Mitsubishi Pharma Corp Verfahren zur aktivierung von protein
US6756431B2 (en) * 2002-04-09 2004-06-29 Crompton Corporation Heterocyclic tin flame retardants/smoke suppressants and halogen-containing polymer composition containing same
DK1610822T4 (en) * 2003-04-02 2019-01-14 Ares Trading Sa Liquid pharmaceutical FSH and LH formulations together with a nonionic surfactant
CA2526099C (en) * 2003-06-20 2013-02-05 Ares Trading Sa Freeze-dried fsh / lh formulations

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4560655A (en) * 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
WO1995012664A1 (en) * 1993-11-03 1995-05-11 Genetics Institute, Inc. Adaption of mammalian cell lines to high cell densities

Also Published As

Publication number Publication date
CN101258236A (zh) 2008-09-03
EP1899454B1 (de) 2012-05-30
EA200800253A1 (ru) 2008-06-30
IL188558A0 (en) 2008-04-13
SI1899454T1 (sl) 2012-08-31
DK1899454T3 (da) 2012-07-09
RS52468B (en) 2013-02-28
CY1112992T1 (el) 2016-04-13
BRPI0612781A2 (pt) 2010-11-30
JP5059757B2 (ja) 2012-10-31
JP2008544758A (ja) 2008-12-11
PL1899454T3 (pl) 2012-10-31
AU2006264917B2 (en) 2011-04-28
ES2388875T3 (es) 2012-10-19
UA91063C2 (ru) 2010-06-25
WO2007003640A1 (en) 2007-01-11
AU2006264917A1 (en) 2007-01-11
MY149621A (en) 2013-09-13
BRPI0612781B8 (pt) 2021-05-25
HRP20120486T1 (hr) 2012-07-31
US20090124006A1 (en) 2009-05-14
KR101346499B1 (ko) 2013-12-31
NO20080580L (no) 2008-01-31
TW200732473A (en) 2007-09-01
US8093052B2 (en) 2012-01-10
EA012840B1 (ru) 2009-12-30
EP1899454A1 (de) 2008-03-19
TWI369401B (en) 2012-08-01
IL188558A (en) 2012-04-30
PT1899454E (pt) 2012-06-25
CA2613867A1 (en) 2007-01-11
BRPI0612781B1 (pt) 2020-09-15
AR054157A1 (es) 2007-06-06
KR20080036599A (ko) 2008-04-28

Similar Documents

Publication Publication Date Title
NO341475B1 (no) Anvendelse av serumfritt kulturmedium for å redusere oksiderte former av rekombinant dimerisk gonadotropin
ES2978863T3 (es) Nuevos análogos de insulina y su uso
AU2017332408B2 (en) Insulin analogs with reduced affinity to insulin receptor and use thereof
US11911443B2 (en) Fusion proteins with extended serum half life
JP2014527818A (ja) Wnt組成物およびそのような組成物の治療的使用
NO341236B1 (no) Fremgangsmåte for produksjon av veksthormon og anvendelse derav
KR20100123697A (ko) Fsh의 액체 포뮬레이션
CZ98197A3 (cs) Použití KGF nebo jeho analogu pro přípravu léčiva pro léčení cukrovky
WO2016172269A2 (en) Insulin analogs having shortened b chain peptides and associated methods